ImmuneBridge

About:

ImmuneBridge is developing allogeneic immunotherapies for cancer.

Website: https://www.immunebridge.com/

Top Investors: Insight Partners, Quiet Capital, Pioneer Fund, Gaingels, M Ventures

Description:

ImmuneBridge is developing allogeneic immunotherapies for cancer. ImmuneBridge's key innovation fosters the development of immune stem cells obtained from cord blood and creates a fresh, adaptable, reliable, and plentiful cellular source for immunotherapies. They are currently looking for natural killer cell-based treatments for hematological cancers. They will then attack solid tumors using the special benefits of their cellular source.